These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 7517895
1. Signal transduction of the GLP-1-receptor cloned from a human insulinoma. van Eyll B, Lankat-Buttgereit B, Bode HP, Göke R, Göke B. FEBS Lett; 1994 Jul 04; 348(1):7-13. PubMed ID: 7517895 [Abstract] [Full Text] [Related]
2. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma. Volz A, Göke R, Lankat-Buttgereit B, Fehmann HC, Bode HP, Göke B. FEBS Lett; 1995 Oct 02; 373(1):23-9. PubMed ID: 7589426 [Abstract] [Full Text] [Related]
3. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. Göke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Göke B. J Biol Chem; 1993 Sep 15; 268(26):19650-5. PubMed ID: 8396143 [Abstract] [Full Text] [Related]
5. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines. Widmann C, Bürki E, Dolci W, Thorens B. Mol Pharmacol; 1994 May 15; 45(5):1029-35. PubMed ID: 8190093 [Abstract] [Full Text] [Related]
11. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence. Serre V, Dolci W, Schaerer E, Scrocchi L, Drucker D, Efrat S, Thorens B. Endocrinology; 1998 Nov 15; 139(11):4448-54. PubMed ID: 9794451 [Abstract] [Full Text] [Related]
12. Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, Boyd AE. Endocrinology; 1993 Jul 15; 133(1):57-62. PubMed ID: 8391428 [Abstract] [Full Text] [Related]
16. Detection of the human glucagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes. Lankat-Buttgereit B, Göke R, Stöckmann F, Jiang J, Fehmann HC, Göke B. Digestion; 1994 Sep 15; 55(1):29-33. PubMed ID: 8112494 [Abstract] [Full Text] [Related]
17. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Munroe DG, Gupta AK, Kooshesh F, Vyas TB, Rizkalla G, Wang H, Demchyshyn L, Yang ZJ, Kamboj RK, Chen H, McCallum K, Sumner-Smith M, Drucker DJ, Crivici A. Proc Natl Acad Sci U S A; 1999 Feb 16; 96(4):1569-73. PubMed ID: 9990065 [Abstract] [Full Text] [Related]
18. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate. Widmann C, Dolci W, Thorens B. Mol Endocrinol; 1996 Jan 16; 10(1):62-75. PubMed ID: 8838146 [Abstract] [Full Text] [Related]
19. Engineered beta-cells secreting dipeptidyl peptidase IV-resistant glucagon-like peptide-1 show enhanced glucose-responsiveness. Islam MS, Rahman SA, Mirzaei Z, Islam KB. Life Sci; 2005 Jan 28; 76(11):1239-48. PubMed ID: 15642594 [Abstract] [Full Text] [Related]
20. The amino terminal domain of the glucagon-like peptide-1 receptor is a critical determinant of subtype specificity. Graziano MP, Hey PJ, Strader CD. Recept Channels; 1996 Jan 28; 4(1):9-17. PubMed ID: 8723643 [Abstract] [Full Text] [Related] Page: [Next] [New Search]